搜索医生

Talal Hilal, M.D.

  1. Hematologist / Oncologist
预约门诊

出版物

  1. Hampel PJ, Rabe KG, Wang Y, Hwang SR, Kenderian SS, Muchtar E, Leis JF, Koehler AB, Tsang M, Hilal T, Parrondo R, Bailen RJ, Schwager SM, Hanson CA, Braggio E, Slager SL, Shi M, Zepeda-Mendoza CJ, Van Dyke DL, Shanafelt TD, King RL, Call TG, Kay NE, Ding W, Parikh SA. Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era. Leukemia. 2024 Dec 10 [Epub ahead of print]
    View PubMed
  2. Aldoss I, Roloff GW, Faramand R, Kopmar NE, Lin C, Advani AS, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Zhang A, Miller K, Sutherland K, Dykes KC, Ahmed M, Chen E, Zambrano H, Bradshaw D, Mercadal S, Schwartz MS, Tracy S, Dholaria B, Kubiak M, Mukherjee A, Majhail N, Battiwalla M, Mountjoy L, Malik SA, Mathews J, Shaughnessy P, Logan AC, Ladha A, Stefan M, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor M, O'Dwyer KM, Hill LC, Tsai SB, Sasine J, Solh MM, Lee CJ, Kota VK, Koura D, Veeraputhiran M, Blunk B, Oliai C, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Bishop MR, Stock W, Cassaday RD, Pullarkat V, Shah BD, Muffly LS. Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL. Blood Adv. 2024 Dec 10; 8 (23):6139-6147
    View PubMed
  3. Islam N, Budvytyte L, Khera N, Hilal T. Disparities in Clinical Trial Enrollment- Focus on CAR-T and Bispecific Antibody Therapies. Curr Hematol Malig Rep. 2024 Dec 4; 20 (1):1 Epub 2024 Dec 04
    View PubMed
  4. Cartagena J, Deshpande A, Rosenthal A, Tsang M, Hilal T, Rimsza L, Kurzrock R, Munoz J. Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable. Curr Oncol Rep. 2024 Dec; 26 (12):1664-1674 Epub 2024 Dec 06
    View PubMed
  5. Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter LG, Sauter C, Hamadani M, Herrera A, Shouval R, Shadman M. CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma. Blood Adv. 2024 Oct 22; 8 (20):5290-5296
    View PubMed
  6. Mountjoy L, Roloff GW, Aldoss I, Kopmar NE, Lin C, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed N, Zhang A, Miller K, Dykes KC, Ahmed M, Chen EC, Mercadal S, Schwartz M, Tracy SI, Dholaria B, Mukherjee A, Battiwalla M, Logan AC, Ladha A, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor MP, Hill LC, Tsai SB, Sasine JP, Solh MM, Kota VK, Koura D, Veeraputhiran M, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Pullarkat V, Stock W, Cassaday RD, Shah BD, Faramand R, Muffly L, ROCCA Consortium. Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL. J Clin Oncol. 2024 Oct 17; JCO2400321 [Epub ahead of print]
    View PubMed
  7. Zhao J, Zhang N, Hilal T, Griffin JM, Yabroff KR, Khera N. Health insurance literacy among patients receiving outpatient cancer treatment. Cancer. 2024 Oct 15; 130 (20):3480-3486 Epub 2024 July 17
    View PubMed
  8. Koehler AB, Rabe KG, Crusan DJ, Call TG, Achenbach SJ, Hampel PJ, Kenderian SS, Leis JF, Wang Y, Muchtar E, Tsang M, Hilal T, Parrondo R, Bailey KR, Ding W, Bailen R, Schwager SM, Shi M, Hanson CA, Slager SL, Kay NE, Ashrani AA, Parikh SA. Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism. J Thromb Haemost. 2024 Sep 27 Epub 2024 Sept 27
    View PubMed
  9. Rios-Olais FA, McGary AK, Tsang M, Almader-Douglas D, Leis JF, Buras MR, Hilal T. Measurable Residual Disease and Clinical Outcomes in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis. JAMA Oncol. 2024 Sep 1; 10 (9):1221-1227
    View PubMed
  10. Wonnaparhown A, Hilal T, Squire J, Freeman C, Fonseca R. IgG replacement in multiple myeloma. Blood Cancer J. 2024 Jul 25; 14 (1):124 Epub 2024 July 25
    View PubMed
  11. Cliff ERS, Hilal T, Kesselheim AS. Complicated regulatory decision-making following inconsistent trial results: the issue with ibrutinib for mantle cell lymphoma. Nat Rev Clin Oncol. 2024 Jan; 21 (1):1-2
    View PubMed
  12. Gaulin C, Craig F, Fortin Ensign S, Robetorye R, Gibson S, Kelemen K, Khera N, Leis J, Tsang M, Rosenthal A, Munoz J, Palmer J, Hilal T. Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms. Leuk Lymphoma 2023 Dec; 64 (14):2347-2350 Epub 2023 Sept 07
    View PubMed
  13. Lee MK, Durani U, Zhang N, Hilal T, Warsame RM, Borah B, Khera N, Griffin JM. Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With Cancer. JCO Oncol Pract. 2023 Oct; 19 (10):888-898 Epub 2023 Aug 24
    View PubMed
  14. Rios-Olais FA, Hilal T. Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice. Curr Treat Options Oncol. 2023 Aug; 24 (8):907-928 Epub 2023 May 17
    View PubMed
  15. Abdo Y, Gibson GD, Jain SP, Milner CP, Hilal T. Treatment of Relapsed B/T-cell Mixed Phenotype Acute Leukemia With Blinatumomab. Cureus. 2023 Jun; 15 (6):e40661 Epub 2023 June 19
    View PubMed
  16. Hilal T, Mountjoy LJ. Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy. Curr Oncol Rep. 2023 Jun; 25 (6):599-607 Epub 2023 Mar 28
    View PubMed
  17. Hilal T. In the trenches. Lancet Haematol. 2023 Mar; 10 (3):e164
    View PubMed
  18. Khera N, Zhang N, Hilal T, Durani U, Lee M, Padman R, Voleti S, Warsame RM, Borah BJ, Yabroff KR, Griffin JM. Association of Health Insurance Literacy With Financial Hardship in Patients With Cancer. JAMA Netw Open. 2022 Jul 1; 5 (7):e2223141 Epub 2022 July 01
    View PubMed
  19. Hilal T, Jain SP. Isolated CNS relapse of blastic plasmacytoid dendritic cell neoplasm. Blood. 2022 Feb 24; 139 (8):1255
    View PubMed
  20. Hilal T. On dialogue and its many forms. Lancet Haematol. 2021 Mar; 8 (3):e171
    View PubMed
  21. Mountjoy L, Sebastian S, Jain T, Hilal T, Gonzalez-Velez M, Girardo M, Ahmann G, Larsen J, Bergsagel L, Fonseca R. Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity. Leukemia 2020 Nov; 34 (11):3060-3063 Epub 2020 June 05
    View PubMed
  22. Hilal T. Tail events with cancer treatment. Lancet Haematol. 2020 Oct; 7 (10):e712
    View PubMed
  23. Hilal T, Gonzalez-Velez M, Prasad V. Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration. JAMA Intern Med. 2020 Aug 1; 180 (8):1108-1115
    View PubMed
  24. Hilal T, Munoz J. Choosing Wisely(R) in Hematology: Have We Made a Difference? Curr Hematol Malig Rep. 2020 Aug; 15 (4):241-247
    View PubMed
  25. Hilal T. Gone But Here. Am J Hosp Palliat Care. 2020 Aug; 37 (8):659-660 Epub 2019 Oct 30
    View PubMed
  26. Sonbol MB, Halfdanarson TR, Hilal T. Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic Review. JAMA Oncol. 2020 Jul 1; 6 (7):1086-1092
    View PubMed
  27. Hilal T, Mi L, Ertz-Archambault NM, Almquist DR, Anderson KS, Gray RJ, Pockaj BA, Northfelt DW. Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer. Breast J. 2020 Jul; 26 (7):1449-1451 Epub 2019 Dec 26
    View PubMed
  28. Sonbol MB, Firwana BM, Hilal T, Murad MH. How to read a published clinical trial: A practical guide for clinicians. Avicenna J Med. 2020 Apr-Jun; 10 (2):68-75 Epub 2019 Apr 01
    View PubMed
  29. Verma A, Sharma A, Robetorye R, Porter A, Hilal T. Intravascular Large B-cell Lymphoma Associated with Systemic and Central Nervous System Hemophagocytic Lymphohistiocytosis: A Case Report. Perm J. 2020; 24 Epub 2019 Dec 06
    View PubMed
  30. Hilal T. Progress in acute myeloid leukaemia: small molecular inhibitors with small benefits. Ecancermedicalscience. 2020; 14:1015 Epub 2020 Feb 27
    View PubMed
  31. Sonbol MB, Jain T, Firwana B, Hilal T, Deleon T, Murad A, Murad MH, Khera N. Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis. BMJ Support Palliat Care. 2019 Dec; 9 (4):425-433 Epub 2019 Apr 04
    View PubMed
  32. Hilal T, Maguire A, Kosiorek HE, Rimsza LM, Rosenthal AC. Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma. Leuk Lymphoma 2019 Dec; 60 (14):3581-3583 Epub 2019 June 27
    View PubMed
  33. Hilal T. Hanging Up the Gloves. Oncologist. 2019 Oct; 24 (10):1403-1404 Epub 2019 May 23
    View PubMed
  34. Hilal T, Mudd J, DeLoughery TG. Hemostatic complications associated with ventricular assist devices. Res Pract Thromb Haemost. 2019 Oct; 3 (4):589-598 Epub 2019 June 09
    View PubMed
  35. Hilal T, Sonbol MB, Prasad V. Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration. JAMA Oncol. 2019 Jun 1; 5 (6):887-892
    View PubMed
  36. Hilal T. I Don't Know. Am J Hosp Palliat Care. 2019 Apr; 36 (4):348-349 Epub 2018 Sept 19
    View PubMed
  37. Al-Husseini MJ, Saad AM, Jazieh KA, Elmatboly AM, Rachid A, Gad MM, Ruhban IA, Hilal T. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups. Int J Colorectal Dis. 2019 Feb; 34(2):285-292. Epub 2018 Nov 15.
    View PubMed
  38. Scheckel CJ, Kosiorek HE, Butterfield R, Ho TH, Hilal T. Germ Cell Tumors with Malignant Somatic Transformation: A Mayo Clinic Experience. Oncol Res Treat. 2019; 42(3):95-100. Epub 2019 Feb 27.
    View PubMed
  39. Hilal T, Prasad V. Eliminating MRD - FDA approval of blinatumomab for B-ALL in complete remission. Nat Rev Clin Oncol. 2018 Dec; 15 (12):727-728
    View PubMed
  40. Hilal T, Patel BK. ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy. Ann Surg Oncol 2018 Dec; 25 (Suppl 3):652-653 Epub 2018 Oct 15
    View PubMed
  41. Hilal T, Covington M, Kosiorek HE, Zwart C, Ocal IT, Pockaj BA, Northfelt DW, Patel BK. Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy. Breast J. 2018 Nov; 24 (6):1010-1014 Epub 2018 July 31
    View PubMed
  42. Hilal T, Wang Z, Almader-Douglas D, Rosenthal A, Reeder CB, Jain T. Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis. Am J Hematol. 2018 Oct; 93 (10):1220-1226 Epub 2018 Sept 03
    View PubMed
  43. Hilal T, Gea-Banacloche JC, Leis JF. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections. Blood Rev. 2018 Sep; 32 (5):387-399 Epub 2018 Mar 16
    View PubMed
  44. Sonbol MB, Hilal T, Dueck AC, Rosenthal AC, Conley CR, Kosiorek HE, Ginos BF, Gano KM, Nichols CS, Leis JF, Johnston PB, Habermann TM, Northfelt DW, Bergsagel PL, Inwards DJ, Witzig TE, Ansell SM, Reeder CB. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. Leuk Lymphoma. 2018 Sep; 59(9):2128-2134. Epub 2018 Jan 10.
    View PubMed
  45. Hilal T, Betcher JA, Leis JF. Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia-the Burden of Novelty. Curr Hematol Malig Rep. 2018 Aug; 13 (4):237-243
    View PubMed
  46. Hilal T, DiCaudo DJ, Connolly SM, Reeder CB. Necrobiotic xanthogranuloma: a 30-year single-center experience. Ann Hematol. 2018 Aug; 97 (8):1471-1479 Epub 2018 Mar 22
    View PubMed
  47. Sonbol MB, Firwana B, Hilal T, Wang Z, Almader-Douglas D, Joseph RW, Ho TH. Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2018 Jun; 1 (2):101-108 Epub 2018 Mar 15
    View PubMed
  48. Hilal T, Leis JF, Reeder CB. Rituximab Maintenance Therapy After First-Line Induction Chemoimmunotherapy for Follicular Lymphoma. JAMA Oncol 2018 Jun 1; 4 (6):859-860
    View PubMed
  49. Patel BK, Hilal T, Covington M, Zhang N, Kosiorek HE, Lobbes M, Northfelt DW, Pockaj BA. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2018 May; 25 (5):1350-1356 Epub 2018 Mar 07
    View PubMed
  50. Hilal T, Bansal P, Kelemen K, Slack J. Nivolumab-associated bone marrow necrosis. Ann Oncol 2018 Feb 1; 29 (2):513-514
    View PubMed
  51. Hilal T, Fauble V, Ketterling RP, Kelemen K. Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement. Cancer Genet. 2018 Jan; 220:13-18 Epub 2017 Oct 23
    View PubMed
  52. Hilal T, Conley CR. B-cell acute lymphoblastic leukemia with +der(1)t(1;19) (p13;p13.1) arising in the setting of CALR exon 9 mutated essential thrombocythemia. Cancer Genet 2017 Dec; 218-219:81-83 Epub 2017 Oct 19
    View PubMed
  53. Hilal T, Nakazawa M, Hodskins J, Villano JL, Mathew A, Goel G, Wagner L, Arnold SM, DeSimone P, Anthony LB, Hosein PJ. Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy. BMC Cancer. 2017 Aug 30; 17 (1):602
    View PubMed
  54. Hilal T, Slone S, Peterson S, Bodine C, Gul Z. Cytomegalovirus reactivation is associated with a lower rate of early relapse in myeloid malignancies independent of in-vivo T cell depletion strategy. Leuk Res. 2017 Jun; 57:37-44 Epub 2017 Mar 01
    View PubMed
  55. Hilal T. Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management. Ther Adv Med Oncol. 2017 Mar; 9 (3):189-199 Epub 2016 Nov 17
    View PubMed
  56. Hilal T. A cause to consider for chronic unresolving diarrhea. Gastroenterol Rep (Oxf). 2016 May; 4: (2)162-4.
    View PubMed
  57. Hilal T, Romond EH. ERBB2 (HER2) Testing in Breast Cancer. JAMA. 2016 Mar 22-29; 315: (12)1280-1.
    View PubMed
  58. Hilal T, Rudy DW. Radiation-induced breast cancer: the question of early breast cancer screening in Hodgkin's lymphoma survivors. Oxf Med Case Reports. 2016 Feb; 2016: (2)17-8.
    View PubMed
  59. Hilal T, Anthony LB, Sorrell VL. Unexpected Cardiac Masses. JAMA Oncol. 2015 Dec; 1: (9)1343-4.
    View PubMed
  60. Hilal T, Snapp WK. The perils of country life: human monocytic ehrlichiosis. Am J Med. 2015 Aug; 128 (8):831-3 Epub 2015 Apr 23
    View PubMed
  61. Hilal T. Bilateral upper lobe opacification. Med J Aust. 2015 Jun 15; 202: (11)586.
    View PubMed
  62. Hilal T . Autoimmune hepatitis associated with an abnormally low ceruloplasmin level Journal of Case Reports in Practice.2015 Apr;3:(2):35-37.
  63. Hilal T, Woods R. A tick-borne illness unmasking asymptomatic Brugada syndrome. Oxf Med Case Reports. 2015 Feb; 2015: (2)191-3.
    View PubMed
  64. Hilal T. Fatal cytomegalovirus disease after combination therapy with corticosteroids and rituximab for granulomatosis with polyangiitis. Case Rep Rheumatol. 2015; 2015:538137.
    View PubMed
  65. Hilal T. Diffuse unresolving pulmonary nodules in a patient with a history of cervical carcinoma. BMJ Case Rep. 2015; 2015:
    View PubMed
  66. Hilal T. Sudden cardiac arrest in a healthy young athlete. BMJ Case Rep. 2015; 2015:
    View PubMed
  67. Hensley P, Hilal T, Neltner J, Kumar B. Maintaining sharp focus on a grainy film: miliary pattern in an elderly woman with acute respiratory failure. BMJ Case Rep. 2015; 2015:
    View PubMed
  68. Hilal T, Gul Z. Exploring the possibilities: airspace disease in the postallogeneic haematopoietic stem cell transplant period. BMJ Case Rep. 2015; 2015:
    View PubMed
  69. Hilal T . Isolated neurocutaneous peripheral T cell lymphoma NOS International Journal of Case Reports and Images.2014 Dec 1;5:(12):859-63.
  70. Hilal T. Chronic rupture of the coronary sinus of Valsalva with pseudoaneurysm formation. Oxf Med Case Reports. 2014 Oct; 2014: (7)120-1.
    View PubMed
  71. Hilal T, Hurley P, McCormick M. Disseminated tuberculosis with tuberculous meningitis in an immunocompetent host. Oxf Med Case Reports. 2014 Oct; 2014: (7)125-8.
    View PubMed
  72. Hilal T . Advanced cutaneous Kaposi’s sarcoma: An uncommon AIDS-related manifestation in the era of antiretroviral therapy International Journal of Case Reports and Images.2014 Oct 1;5:(10):731-33.
  73. Hilal T, Morehead RS. Fulminant Wilson's Disease Managed with Plasmapheresis as a Bridge to Liver Transplant. Case Rep Med. 2014; 2014:672985.
    View PubMed
PST-20324175